Clinical trial
Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant…
NCT00179244 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00179244 |
|---|---|
| Title | Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression |
| Official title | Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | Janssen Pharmaceutica Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Unipolar Depression |
| Intervention type | Drug |
| Interventions | Rispridone (drug) and Bupropion ER (drug) |
| Enrollment | 30 |
| Start date | Jul 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: